Requiring patients to help pay for their statin medications has a negative impact on adherence to the therapy, according to a study published in the April 10, 2007, issue of Circulation. Researchers found that addition of a fixed $20 co-payment or 25% coinsurance reduces adherence to statin therapy by 5%, with larger reductions in adherence observed in low-income patients.
Requiring patients to help pay for their statin medications has a negative impact on adherence to the therapy, according to a study published in the April 10, 2007, issue of <I>Circulation</I>. Researchers found that addition of a fixed $20 co-payment or 25% coinsurance reduces adherence to statin therapy by 5%, with larger reductions in adherence observed in low-income patients.
Statin adherence goes down with cost-sharing
October 1, 2007